Von Hippel-Lindau Syndrome in a Private Cancer Service in São Paulo: Case Report
DOI:
https://doi.org/10.32635/2176-9745.RBC.2023v69n1.2686Keywords:
von Hippel-Lindau disease, germ-line mutation, hemangioblastomaAbstract
Introduction: Von Hippel-Lindau (VHL) syndrome is an autosomal dominant hereditary pathology that involves the growth of tumors in different regions of the human body due to mutation of the VHL gene. Case report: Male patient, 38 years old, complained of recurrent headache for 3 years, with progressive worsening. A lesion in the cerebellum was diagnosed, whose magnetic resonance imaging found an expansive formation in the posteroinferior portion of the left cerebellar hemisphere. Multislice tomography of the abdomen was performed, showing splenic nodular formation with marginal enhancement. Cervical spine imaging demonstrated a small nodule located in the cervical (intramedullary) cord adjacent to cervical vertebra 3 (C3). In view of the findings, the patient underwent total macroscopic resection of the cerebellar lesion, with an anatomopathological report of World Health Organization (WHO) grade 1 cerebellar hemangioblastoma, which is a benign tumor with lower risk of aggressiveness and recurrence. Immunohistochemical test showed positive cluster of differentiation 34 (CD34), cell proliferation index positive (Ki67) (<5%), positive alpha inhibin and epithelial membrane antigen (EMA) negative. As the patient had no family history of cancer, a new generation sequencing was performed due to the radiological findings, which identified the pathogenic variant VHL c.292T>C found in germ lineage; although the family was unaware of any past family history of the syndrome, the patient’s diagnosis was confirmed. Conclusion: The set of clinical findings and the variant in the VHL gene confirm the diagnosis of the syndrome.
Downloads
References
Hamosh A, Scott AF, Amberger J, et al. Online Mendelian Inheritance in Man (OMIM). Human Mutation. 2000;15(1):57-61. doi: https://doi.org/10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G DOI: https://doi.org/10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G
Findeis-Hosey JJ, McMahon KQ, Findeis SK. Von Hippel-Lindau disease. J Pediatr Genet. 2016;5(2):116-23. doi: https://doi.org/10.1055/s-0036-1579757 DOI: https://doi.org/10.1055/s-0036-1579757
Fujita PA, Rhead B, Zweig AS, et al. The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 2011;39(Suppl 1):D876-82. doi: https://doi.org/10.1093/nar/gkq963 DOI: https://doi.org/10.1093/nar/gkq963
Maher ER, Sandford RN. von Hippel-Lindau disease: an Update. Curr Genet Med Rep. 2019;7:227-35. doi: https://doi.org/10.1007/s40142-019-00180-9 DOI: https://doi.org/10.1007/s40142-019-00180-9
Gatti R, Pereira MAA, Giannella Neto D. Síndrome de von Hippel-Lindau. Arq Bras Endocrinol Metab. 1999;43(5):377-88. doi: https://doi.org/10.1590/S0004-27301999000500011 DOI: https://doi.org/10.1590/S0004-27301999000500011
Nielsen SM, Rhodes L, Blanco I, et al. Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. J Clin Oncol. 2016;34(18):2172-81. doi: https://doi.org/10.1200/jco.2015.65.6140 DOI: https://doi.org/10.1200/JCO.2015.65.6140
Friedrich CA. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer. 1999;86(11 Suppl):2478-82. doi: https://doi.org/10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5 DOI: https://doi.org/10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5
Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61(3):215-25. doi: https://doi.org/10.1093/jnen/61.3.215 DOI: https://doi.org/10.1093/jnen/61.3.215
Liu P, Zhu F, Li M, et al. Von Hippel-Lindau “Black Forest” mutation inherited in a large Chinese family. Gland Surg. 2019;8(4):343-53. doi: https://doi.org/10.21037/gs.2019.08.03 DOI: https://doi.org/10.21037/gs.2019.08.03
Nykamp K, Anderson M, Powers M, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. 2017;19(10):1105-17. doi: https://doi.org/10.1038/gim.2017.37 DOI: https://doi.org/10.1038/gim.2017.37
Louise M Binderup M, Smerdel M, Borgwadt L, et al. von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance. Eur J Med Genet. 2022;65(8):104538. doi: https://doi.org/10.1016/j.ejmg.2022.104538 DOI: https://doi.org/10.1016/j.ejmg.2022.104538
Conselho Nacional de Saúde (BR). Resolução nº 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção 1:59.
Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317-20. doi: https://doi.org/10.1126/science.8493574 DOI: https://doi.org/10.1126/science.8493574
Crossey PA, Richards FM, Foster K, et al. Identification of intragenic mutations in the Von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet. 1994;3(8):1303-8. doi: https://doi.org/10.1093/hmg/3.8.1303 DOI: https://doi.org/10.1093/hmg/3.8.1303
Lenglet M, Robriquet F, Schwarz K, et al. Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease. Blood. 2018;132(5):469-83. doi: https://doi.org/10.1182/blood-2018-03-838235 DOI: https://doi.org/10.1182/blood-2018-03-838235
van Leeuwaarde RS, Ahmad S, Links TP, et al. Von Hippel-Lindau syndrome. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2022 Sep 16]. Available from: https://pubmed.ncbi.nlm.nih.gov/20301636/
Varshney N, Kebede AA, Owusu-Dapaah H, et al. A review of Von Hippel-Lindau syndrome. J Kidney Cancer VHL. 2017;4(3):20-9. doi: https://doi.org/10.15586/jkcVHL.2017.88 DOI: https://doi.org/10.15586/jkcvhl.2017.88
Mikhail MI, Singh AK. Von Hippel Lindau syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [cited 2022 abr 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459242/
Binderup MLM, Jensen AM, Budtz-Jørgensen E, et al. Survival and causes of death in patients with von Hippel-Lindau disease. J Med Genet. 2017;54(1):11-18. doi: https://doi.org/10.1136/jmedgenet-2016-104058 DOI: https://doi.org/10.1136/jmedgenet-2016-104058
Chittiboina P, Lonser RR. Von Hippel-Lindau disease. Handb Clin Neurol. 2015;132:139-56. doi: https://doi.org/10.1016/B978-0-444-62702-5.00010-X DOI: https://doi.org/10.1016/B978-0-444-62702-5.00010-X
VHL Alliance. Lo que se necesita saber sobre la enfermedad de von Hippel-Lindau: Un manual de referencia para individuos con von-Hippel-Lindau (VHL), sus familias y sus equipos médicos. 6 ed. Rev. Boston (MA): VHL Alliance; 2020 [acesso 2022 abr 12]. Disponível em: https://www.vhl.org/storage/2023/01/El-Manual-de-la-VHLA_2021-Spanish-VHL-Handbook.pdf
Schmid S, Gillessen S, Binet I, et al. Management of von hippel-lindau disease: an interdisciplinary review. Oncol Res Treat. 2014;37(12):761-71. doi: https://doi.org/10.1159/000369362. Erratum in: Oncol Res Treat. 2015;38(1-2):50. doi: https://doi.org/10.1159/000375284 DOI: https://doi.org/10.1159/000369362
Wolters WPG, Dreijerink KMA, Giles RH, et al. Multidisciplinary integrated care pathway for von Hippel-Lindau disease. Cancer. 2022;128(15):2871-9. doi: https://doi.org/10.1002/cncr.34265 DOI: https://doi.org/10.1002/cncr.34265
Tsingeli P, Papadatou MC, Psillaki D, et al. Rehabilitation management in two siblings with Von Hippel-Lindau syndrome: a case series. J Musculoskelet Neuronal Interact. 2021;21(2):326-31. Cited in: PubMed; PMID 34059579.
Gläsker S, Vergauwen E, Koch CA, et al. Von Hippel-Lindau disease: current challenges and future prospects. Onco Targets Ther. 2020;13:5669-90. doi: https://doi.org/10.2147/OTT.S190753 DOI: https://doi.org/10.2147/OTT.S190753
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.